US Capitol Capsule: Forget Sovaldi; generics new pricey drugs poster child
This article was originally published in Scrip
Executive Summary
Move over Sovaldi. US lawmakers have a new poster child for high drug prices: older, off-patent medicines, usually sold as generics, which are supposed to be the answer to saving Americans money in lieu of paying for pricey innovator therapies.